# Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (Text with EEA relevance), Division 1.2.8: Route of administration

Extent: E+W+S+N.I.

In the risk assessment, the manufacturer must take into account the route of administration as indicated in the product information.

---
Source: https://www.legislation.gov.uk/eur/2012/722/annex/I/division/1/division/1.2/division/1.2.8 (the official version)
Page: https://openlegislation.uk/eu-regulation-2012-722/annex-I/division-1/division-1.2/division-1.2.8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.